The possibility of accessing phospholane units with
different substituents at the 2- and 5-positions has allowed
the steric fine-tuning necessary to obtain the best results over
a wide range of substrates.6 For example, Me-DuPHOS and
Et-DuPHOS (2a and 2b, respectively) usually provide the
best rhodium catalysts for the asymmetric hydrogenation of
dehydroamino acids3 and â-monosubstituted itaconates,7
while Me-BPE 1a is the ligand of choice for the rhodium-
catalyzed hydrogenation of â,â-disubstituted itaconates.7
An obvious modular extension to the 2,5-disubstituted
bisphospholane family of ligands are the aryl analogues.
However, these ligands have so far proved to be elusive.
The preferred method for the preparation of the dialkyl
phospholanes is the reaction of an appropriately substituted
cyclic sulfate, derived from the corresponding enantiomeri-
cally pure diol, with a lithiated phosphide.3 However, with
diaryl cyclic sulfates and dimesylates elimination or race-
mization is observed. The avoidance of such problems in
the formation of a 2,5-diphenyl phospholane unit has been
addressed in recent disclosures by Fiaud and co-workers on
the synthesis of 1-phenyl-2,5-diphenylphospholane 3.8 Using
these key publications as impetus, we endeavored to syn-
thesize the chiral phospholane ligand 1,2-bis(2,5-phenylphos-
pholano)ethane (Ph-BPE) 4 from phospholanic acid 5.
Herein, we report the synthesis of the Ph-BPE ligand and
its use in rhodium-catalyzed asymmetric hydrogenation.
The enantiomerically pure phospholanic acid 5 was
prepared and resolved according to the method reported by
Fiaud.8 Scheme 1 depicts the series of steps that led us from
framework was then accomplished by deprotonation of
adduct 6 with n-BuLi and reaction with 1,2-ethylene di-
tosylate to give bisphospholane 7. No formation of the
unwanted meso-compound was detected at this stage. The
formation of Ph-BPE 410 was finally realized by deprotection
of 7 with HBF4.11 The optical purity of Ph-BPE 4 was
confirmed by oxidation of a sample to the corresponding
phosphino-oxide and analysis by chiral HPLC.12
This pathway represents a reversal of the established
strategy for the synthesis of bidentate phospholane-based
ligands. The phospholane ring is constructed as a distinct
entity prior to attachment to the backbone rather than being
assembled at the end of the synthesis.
With the long sought after Ph-BPE ligand in hand, we
were able to test its performance in homogeneous asymmetric
hydrogenation and compare it with the other members of
the BPE ligand family. To this end, the rhodium complex
[(R,R)-Ph-BPE Rh COD]BF4 was prepared by reaction of
the free ligand with [Rh(COD)2]BF4 and tested against a
series of substrates.
Hydrogenation of methyl acetamidocinnamate 8 at a molar
substrate-to-catalyst ratio (S/C) of 3000 immediately indi-
cated that substantially improved activity and selectivity is
achieved with the Ph-BPE rhodium catalyst compared with
the other BPE rhodium catalysts (Table 1). The level of
Table 1. Asymmetric Hydrogenation of Methyl
Acetamido-cinnamate Using Rhodium BPE Catalystsa
Scheme 1. Preparation of the Ph-BPE Liganda
entry
ligand
time (min)
conversion (%)c
ee (%)c
1
2
3
4
(R,R)-1a
(R,R)-1b
(S,S)-1c
(R,R)-4
90
120
840
75
100
100
83
85 (R)d
88 (R)
94 (R)
99 (S)
100
a Reactions were performed simultaneously in an Argonaut Endeavor
reaction vessel with 1.5 M solutions of substrate in MeOH at 28 °C under
10 bar hydrogen pressure. b Molar substrate-to-catalyst ratio. c Conversion
and enantiomeric excess were determined by chiral GC. d Product stereo-
chemistry and enantioselectivity are consistent with that stated in ref 2b.
a Reagents and conditions: (a) (i) PhSiH3, toluene, 110 °C, 16
h; (ii) BH3‚SMe2, THF, from 0 °C to rt (95%). (b) n-BuLi, THF,
from -78 °C to rt, 30 min, then TsOCH2CH2OTs, THF, rt, 40 h
(69%). (c) HBF4‚OMe2, CH2Cl2, rt, 16 h (92%).
selectivity (99% ee) is comparable to that obtained with the
best DuPHOS ligands.13 Surprisingly, i-Pr-BPE gave much
lower activity than expected.
phospholanic acid 5 to Ph-BPE 4. Phospholanic acid 5 was
reduced using PhSiH3 and subsequently treated with BH3‚
SMe2 to afford borane adduct 6. Synthesis of the BPE
(10) 1H NMR (400 MHz, CDCl3) δ 0.57 (m, 2H), 0.96 (m, 2H), 1.76-
1.86 (m, 2H), 2.05-2.15 (m, 2H), 2.27 (m, 2H), 2.48 (m, 2H), 2.95 (m,
2H), 3.59 (m, 2H), 7.08 (m, 6H), 7.16 (m, 4H), 7.21 (m, 6H), 7.30 (m,
4H); 31P NMR (162 MHz, CDCl3) δ 16.01; 13C NMR (100.6 MHz, CDCl3)
δ 21.45 (dd, JCP ) 36.0 Hz, JCCP ) 27.1 Hz, bridge CH2), 31.92 (s, ring
CH2), 37.38 (s, ring CH2), 46.15 (m, ring CH), 50.57 (m, ring CH), 125.75
(s), 125.83 (s), 127.25 (s), 127.86 (m), 128.30 (s), 128.53 (s), 138.33 (m,
ipso-CAr), 144.65 (m, ipso-CAr); HRMS (EI) m/z calcd for C34H36P2
506.2292, found 506.2269; [R]D ) -174.9 (c ) 0.3, CH2Cl2).
(11) McKinstry, L.; Livinghouse, T. Tetrahedron 1995, 51, 7655.
(12) Chialpak AD-H (250 × 4.6 mm), heptane/EtOH 80/20, 1 mL/min,
25°C, detection by UV at 210 nm: 9.5 min (S,S), 15.2 min (R,R), 22.9 min
(meso); >98% ee.
9
(6) Burk, M. J. Acc. Chem. Res. 2000, 33, 363.
(7) Burk, M. J.; Bienewald, F.; Harris, M.; Zanotti-Gerosa, A. Angew.
Chem., Int. Ed. 1998, 37, 1931.
(8) (a) Guillen, F.; Fiaud, J-. C. Tetrahedron Lett. 1999, 40, 2939. (b)
Guillen, F.; Rivard, M.; Toffano, M.; Legros, J-. Y.; Daran, J-. C.; Fiaud,
J-. C. Tetrahedron 2002, 58, 5895.
(9) Soulier, E.; Cle´ment, J-. C.; Yaouanc, J-. J.; des Abbayes, H.
Tetrahedron Lett. 1998, 39, 4291.
1274
Org. Lett., Vol. 5, No. 8, 2003